Highland Capital Partners’ new SPAC filed for an IPO of 25 million units priced at $10 each. The SPAC said it is focused on the travel & leisure, financial services, health & wellness, music & entertainment, media & mobile, and renewable energy/resource efficiency sectors. Read more.
Related Posts
BioPlus Acquisition Files Investor Presentation on $195M Avertix Medical Deal
Avertix is a medical implant company focused on improving long-term management and outcomes of high-risk coronary disease in patients who have survived one or more heart attacks.
dMY Technology Group IV Prices $300M Upsized IPO
The new SPAC intends to concentrate on companies within the broader consumer technology ecosystem that are either consumer-facing or support the infrastructure of consumer applications with enterprise valuations of $1 billion to $3 billion.
Orion Biotech Opportunities Prices $200M IPO
The SPAC will target a company in the life sciences and biotechnology sectors.
Corner Growth Revises Investor Presentation on Noventiq Deal
The deal with the cybersecurity company has a target cash raise of $50 million, with no minimum amount required to close.